Lipid CME

Saving the Hearts of Women Through Prevention

Author(s)/Faculty: Martha Gulati, MD, MS, FACC, FAHA, FASPC; Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Harold E. Bays, MD, FOMA, FTOS, FACC; Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA; Charles German, MD, MS; Ann Marie Navar, MD, PhD; Michael D. Shapiro, DO, MCR, FACC; Priyanka Satish, MD; Pam R. Taub, MD, FACC, FASPC
Release Date: 9/30/2022Expiration Date: 9/29/2023
Credit Type: CMENumber of Credits: 2
Content Type: LectureProvider:
Cardiovascular disease (CVD) is the leading cause of death globally, and women are disproportionately affected, showing higher morbidity and mortality rates than men. This trend has continued despite recent advances in awareness campaigns, gender-based guidelines, as well as effective available therapies. In the United States, heart disease is the leading cause of death, and women have a significantly higher 30-day mortality rate after a new CVD event compared with men. In addition to traditional CV risk factors, women often carry several nontraditional risk factors, many of which are related to pregnancy, hormonal influences, or comorbid disorders. Furthermore, women are less likely to receive guideline-recommended diagnostic testing and therapies. The faculty for this CME activity, Saving the Hearts of Women Through Prevention, address CVD risk factors, tools, and guidelines related to screening females for CV risk. They also examine recent advances in lifestyle modifications, primary and secondary prevention, and considerations for women with type 2 diabetes and dyslipidemia, as well as the impact of weight loss to improve health outcomes and reduce CVD mortality in women.